From Hong Kong to Global: Laservall Drives New Industrialisation and Microelectronics Innovation with HKD 300M Investment
HKSTP park company Laservall aims to advance high-precision laser technology with AI-driven automation, empowering advanced manufacturing through microelectronics innovation
HONG KONG SAR - Media OutReach Newswire - 31 March 2025 - Laservall today announced a landmark HKD 300 million (USD 38 million) investment plan for the next five years. This strategic commitment focuses on R&D, manufacturing and technology enhancement, and tech talent development in Hong Kong. A key park company of the Hong Kong Science and Technology Parks Corporation (HKSTP), Laservall leverages Hong Kong's strategic role as the 'super-connector' between the Mainland and the global market to expand its investment for further operational advancement, benefiting from the city's comprehensive innovation and technology (I&T) ecosystem and supportive policies for new industrialisation. Laservall underscores its long-term investment in Hong Kong at an event co-organised with HKSTP, celebrating the significant R&D milestone and marking the company's expanding global footprint.
Laservall today announced a landmark HKD 300 million (USD 38 million) investment plan for the next five years, celebrating the significant R&D milestone and marking the company's expanding global footprint at an event co-organised with HKSTP. (From left) Mr. Vincent Lau, COO of Laservall; Ms. Dembai Cho, Co-founder of Laservall; Mr. Jeffrey Chan, CFO of Laservall; Mr. Andrew Kim, CEO of Laservall; Mr. James Kang, Chairman of Laservall; Ms. Jaeyon Lee, Consul (Commerce), Consulate General of the Republic of Korea in Hong Kong; Professor Sun Dong, Secretary for Innovation, Technology, and Industry; Ms. Lillian Cheong, Under Secretary for Innovation, Technology and Industry; Mr. Albert Wong, Chief Executive Officer of HKSTP; Mr. Oscar Wong, Head of Innofacturing of HKSTP; Ms Hilda Chan, Chief Marketing Officer of HKSTP, and Dr. Carmen Fung, Associate Director, Advanced Manufacturing and Microelectronics of HKSTP.
The company is at the forefront of driving advanced manufacturing and microelectronics innovation, and is the exclusive provider for some leading global brands. Laservall specialises in micro laser jet soldering, cutting, and marking equipment for smartphone and EV camera modules. Its high-precision solutions and automation systems serve major global clients, including Samsung, LG, Tesla, BYD, and leading manufacturers such as Foxconn, Sunny Optical, Luxshare, and OFILM.
Professor Sun Dong, Secretary for Innovation, Technology and Industry, said, 'Laservall announces its plan of investing HKD 300 million over the next five years and doubling the size of its R&D team by 2026, and extending their R&D team eventually by sixfold by 2028. This not only reflects the company's commitment to innovation but also its unwavering confidence in Hong Kong's I&T industry. Its expansion at the Science Park is a perfect example of how it is leveraging Hong Kong's unique role as a 'super-connector' and a 'super value-adder' to strengthen its presence in the global market.' He expressed confidence that more local companies, like Laservall, will step onto the global I&T stage and demonstrate the remarkable outcomes of Hong Kong's R&D capabilities to the world in the near future.
Albert Wong, CEO of HKSTP, remarked: 'Laservall's investment and growth exemplify the robust foundation Hong Kong provides for cutting-edge innovation. As the global leader in advanced manufacturing, the company's continued commitment to R&D and its expansion in Hong Kong further solidify our city as a powerhouse for microelectronics and advanced manufacturing. This milestone is not just a win for Laservall but a significant boost to strengthening our global standing in shaping the future of new industrialisation.'
Laservall: A Key Catalyst of New Industrialisation at the Heart of the HKSTP I&T Powerhouse
The Hong Kong Special Administrative Region (HKSAR) Government is committed to advancing new industrialisation in Hong Kong with an industry-oriented approach to drive diversified economic growth. Comprehensive support is proactively provided to accelerate the development of strategic industries through initiatives such as the 'New Industrialisation Acceleration Scheme' (NIAS), 'New Industrialisation Funding Scheme' (NIFS), and the upcoming 'Pilot Manufacturing and Production Line Upgrade Support Scheme (Manufacturing+)'.
The HKSAR Government is actively connecting high-potential local and overseas companies to seize the promising opportunities of new industralisation in Hong Kong. In August 2024, a delegation from the HKSAR Government visited Laservall's Smart R&D and Manufacturing Centre in Korea. The visit aimed to introduce various support measures to Laservall and strengthen collaboration on I&T between Hong Kong and Korea in strategic industries, including life and health technology, artificial intelligence and data science, advanced manufacturing, and new energy technology.
James Kang, Chairman of Laservall, said: 'Laservall is proud to be a park company of HKSTP. We are a technology-focused company with significant R&D investment to tailor innovations for our clients globally. This investment will drive advancements in AI-driven automation, real-time troubleshooting, and efficiency improvements.' The company also aims to double its global R&D workforce by 2026 and expand it sixfold by 2028, reinforcing Hong Kong as its global R&D headquarters, with potential plan to set up an advanced production base in the city.'
Andrew Kim, CEO of Laservall, said, 'The trend of utilising high-precision laser technology for camera modules is essential and rapidly gaining momentum across various industries. Hong Kong offers direct access to the vast Mainland market and international connectivity, supported by a robust I&T ecosystem, as well as favourable policies and measures for new industrialisation from the HKSAR Government and HKSTP. This gives us the confidence to expand our investments in the city, positioning us as pioneers of innovation for the next global success.'
A New Chapter for Microelectronics Innovation from Hong Kong
In March 2024, Laservall established an R&D centre at Science Park, focusing on customising its solutions for industries beyond mobile phone manufacturing, including the automotive and solar energy sectors. The integration of AI into manufacturing automation, combined with its commitment to advancing the microelectronics ecosystem, aligns seamlessly with HKSTP's mission to accelerate industry transformation and drive cutting-edge technological advancements.
With 270 microelectronics-related companies within its ecosystem, HKSTP is at the forefront of microelectronics development, offering extensive infrastructure that supports the entire product lifecycle. This includes the Microelectronics Centre (MEC) at Yuen Long InnoPark, along with specialised facilities such as the Hardware Lab, Sensor Lab, and Heterogeneous Integration Lab.
Hashtag: #HKSTP
The issuer is solely responsible for the content of this announcement.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 as a thriving I&T ecosystem grooming 14 unicorns, more than 15,000 research professionals and over 2,200 technology companies from 26 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.
The growing engine offers comprehensive support including R&D infrastructure, investment expertise, industry connections and more, in attracting and nurturing talent, accelerating ideation, and commercialising innovation for technology ventures, all with the I&T journey built around key locations across Hong Kong and branched towards Shenzhen to continuously contribute to the development of I&T making a pillar of growth for Hong Kong.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Entrepreneur
an hour ago
- Entrepreneur
Researchers develop more efficient language model control method
A team of researchers has successfully developed a more efficient method to control the outputs of large language models (LLMs), addressing one of the key challenges in artificial intelligence text... This story originally appeared on Calendar A team of researchers has successfully developed a more efficient method to control the outputs of large language models (LLMs), addressing one of the key challenges in artificial intelligence text generation. The breakthrough enables more effective guidance of LLMs to produce text that adheres to specific structures while maintaining accuracy. The new approach focuses on controlling language model outputs to adhere to predetermined structures, such as programming languages, while eliminating errors that commonly plague AI-generated content. This advancement represents a significant step forward in making AI language tools more reliable for specialized applications. Improving Structural Adherence in AI Text Generation The research addresses a fundamental issue with large language models: their tendency to generate text that deviates from required formats or contains errors when tasked with producing structured content. By implementing more effective control mechanisms, the researchers have developed a system that maintains structural integrity throughout the generation process. For programming languages specifically, this advancement could reduce the frequency of syntax errors and logical flaws that often appear in code generated by AI systems. The method ensures that the language model adheres to the programming language's rules while generating functional code. Technical Approach and Implementation While specific technical details of the method were not fully outlined, the approach appears to involve guiding the language model's generation process more precisely than previous methods. Rather than simply prompting the model and hoping for correctly structured output, the new system actively steers the generation process to maintain compliance with predefined rules. This control mechanism works by: Monitoring the model's outputs in real-time Applying constraints that keep text generation within acceptable parameters Correcting potential errors before they appear in the final output Practical Applications The improved control method opens up new possibilities for utilizing large language models in fields that require strict adherence to specific formats. Some potential applications include: Software Development: Generating error-free code that adheres to the syntax rules of specific programming languages can make AI coding assistants more reliable for developers. Data Formatting: Creating structured data outputs like JSON, XML, or CSV files with perfect adherence to format specifications. Technical Documentation: Producing documentation that follows industry-standard formats without introducing structural errors. Scientific Research: Generating properly formatted research papers or reports that adhere to publication guidelines. Future Research Directions This advancement likely represents an early step in a broader effort to make large language models more controllable and reliable. Future research may expand on this work by: Developing more sophisticated control mechanisms that can handle increasingly complex structural requirements. Reducing the computational overhead associated with implementing these controls, making them more accessible for wider use. Extending the approach to handle multiple types of structured outputs simultaneously. The research highlights the growing focus on not just making AI language models more powerful, but also more precise and controllable. As these systems become increasingly integrated into professional workflows, the ability to guarantee structured, error-free outputs becomes critical. For industries that rely on structured data and formatted text, this development may signal a shift toward more practical and reliable AI assistance tools that can consistently follow rules while maintaining the creative and analytical capabilities that make large language models valuable. The post Researchers develop more efficient language model control method appeared first on Calendar.
Yahoo
3 hours ago
- Yahoo
Helix BioPharma Corp. Announces CFO Appointment to Support Strategic Growth and Upcoming Milestones
TORONTO, ONTARIO - June 2, 2025 (NEWMEDIAWIRE) - Helix BioPharma Corp. (TSX: "HBP", OTC PINK: "HBPCD", FRANKFURT: "HBP0") ("Helix" or the "Company"), a clinical-stage oncology company shaping a near future where today's hard-to-treat cancers are vincible, today announced that the Company has appointed Rohit Babbar, CPA as Chief Financial Officer ("CFO") of the Company, replacing James B. Murphy, CPA as Fractional CFO. Rohit Babbar is Certified Public Accountant with fourteen years of experience leading accounting operations and financial strategy across fast-growing private and publicly listed small to mid-sized companies in Canada and the US. He is a Director at Brio Financial Group ("Brio"), a financial consulting firm that provides outsourced CFO services, financial planning and analysis, and strategic advisory support to emerging growth companies. Over the course of his career, Mr. Babbar has delivered impact across strategic growth and operational efficiency, leading transformative initiatives such as a USD 50 million private equity deal that helped drive a tenfold revenue increase from USD 20 million to USD 200 million. Mr. Babar will be supported by an experienced team of professionals from Brio specializing in accounting and finance, capital raising and administrative operations, as Helix enters a new phase of growth that includes plans to relocate to the US, pursue a NASDAQ listing, and close a substantial equity financing to support upcoming clinical studies. "Rohit's leadership and Brio's support will provide the bandwidth we need as we prepare to execute on the Company's upcoming strategic milestones - particularly as we gear up for our interactions with the FDA - ensuring our financial operations are aligned and fully resourced to support clinical execution," said Dr. Thomas Mehrling, MD, PhD, CEO of Helix BioPharma. Rohit Babbar, CPA, CFO of Helix added: "I'm excited to join Helix at such a pivotal stage in its evolution. The Company's scientific foundation and strategic direction present a compelling opportunity to build long-term value. I look forward to working closely with the team to help drive its financial strategy and support its upcoming milestones." About Brio Financial Group Brio Financial Group is a financial and management consulting firm based in Somerville, New Jersey, specializing in outsourced financial leadership and reporting support for small to mid-sized public and private companies. With a team experienced across domestic and international markets, Brio has supported clients listed on multiple stock exchanges and is frequently referred by leading audit firms - including sole practitioners and Big Four firms alike. Brio's services span complex financial analysis, accounting for mergers and acquisitions, valuation of financial instruments, and the development of robust financial reporting frameworks. In addition to ensuring compliance and managing financial reporting and taxation, the firm provides strategic financial management solutions, including budgeting, modeling, capital procurement, and accounting system design. Brio is known for helping emerging growth companies navigate financial complexity with clarity and confidence. About Helix BioPharma Corp. Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today's hardest-to-treat cancers. The Company's pipeline is led by Tumor Defense Breaker(TM) L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today's front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix's next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery. The Company also advances two pre-IND candidates: (i) LEUMUNA(TM), an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and (ii) GEMCEDA(TM), a first-in-class oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers. Helix is listed on TSX (HBP), OTC PINK (HBPCD), and FWB (HBP0). For more information, please visit: For more information, please contact:Helix BioPharma Adelaide Centre - North Tower40 Temperance Street, Suite 2Toronto, ON M5H 0B4Tel: +1 857 208 7687Jacek Antas, Directorcorporate@ Forward-Looking Statements and Risks and Uncertainties This news release contains forward-looking statements and information (collectively, "forward-looking statements") within the meaning of applicable Canadian securities laws. Forward-looking statements are statements and information that are not historical facts but instead include financial projections and estimates, statements regarding plans, goals, objectives, intentions and expectations with respect to the Company's future business, operations, research and development, including the Company's activities relating to DOS47, LR 09 and GEMCEDA. Forward-looking statements can further be identified by the use of forward-looking terminology such as "ongoing", "estimates", "expects", or the negative thereof or any other variations thereon or comparable terminology referring to future events or results, or that events or conditions "will", "may", "could", or "should" occur or be achieved, or comparable terminology referring to future events or results. Forward-looking statements are necessarily based on a number of estimates and assumptions that the Company considered appropriate and reasonable as of the date such information is given, including but not limited to the assumptions regarding the implied benefits of the transactions. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors, many of which are beyond the Company's control, that may cause actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, including but not limited to the risk that the Company's assumptions on which its forward-looking statements are based may not be accurate; the ability of the Company to capitalize on the potential benefits of the transactions; and the risk factors disclosed in the Company's periodic reports publicly filed and available on its SEDAR+ profile at No assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur. There is no assurance that the proposed transactions will be completed in accordance with its terms or at all. The forward-looking statements contained in this news release are made as of the date of this announcement and the Company does not assume any obligation to update any forward-looking statement or information should those beliefs, assumptions, opinions or expectations, or other circumstances change, except as required by law. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
E3 Lithium Provides Notice of Annual General Meeting and Announces Director Nominations
CALGARY, Alberta, June 02, 2025--(BUSINESS WIRE)--E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3 Lithium" or the "Company," a leader in Canadian lithium, has set the Annual General Meeting (AGM) date to July 2, 2025. AGM Details: The Annual General Meeting of Shareholders will be held on Wednesday, July 2, 2025, at 10am. The Notice of the Meeting information will be distributed shortly to all shareholders, will also available under the Company's profile on SEDAR + ( and available on the Company website ( We look forward to any interested shareholders attending the AGM. John Pantazopoulos, Chairperson of the Board of Directors (the "Board") will be retiring from the Board and will not seek re-election at the AGM to pursue a career in public office. Mr. Pantazopoulos will serve as the Chairperson until the AGM and the Board will elect a new chair following the AGM. Over the past 2 years, in line with the Board's strategic planning, the Board has added three board members with diverse experience in the automotive industry, the lithium industry and government and policy. The number of directors will be set at five (5) with the incumbent directors nominated for the upcoming AGM. Mr. Pantazopoulos has been a director of E3 Lithium since 2020 and has served as the CFO and Chairperson during that time. The Board of Directors and the Company's management team would like to thank John for his many years of service and valuable contributions to E3 and wish him well in his future in politics. "I would like to thank John for his leadership and significant commitment to E3 Lithium over the years," said Chris Doornbos, President and CEO. "John is running for city councillor Ward 6 in Calgary and we wish him the best this new endeavour. I will miss our regular conversations and appreciate the many contributions and sound advice he provided during some significant growth years at E3." ON BEHALF OF THE BOARD OF DIRECTORSChris Doornbos, President & CEOE3 Lithium Ltd. About E3 Lithium E3 Lithium is a development company with a total of 16.2 million tonnes of lithium carbonate equivalent (LCE) Measured and Indicated 1 as well as 0.9 million tonnes LCE Inferred mineral resources2 in Alberta and 2.5 million tonnes LCE Inferred mineral resources3 in Saskatchewan. The Clearwater Pre-Feasibility Study outlined a 1.13 Mt LCE proven and probable mineral reserve with a pre-tax NPV8% of USD 5.2 Billion with a 29.2% IRR and an after-tax NPV8% of USD 3.7 Billion with a 24.6% IRR1. E3 Lithium's goal is to produce high purity, battery grade lithium products to power the growing electrical revolution. With a significant lithium resource and innovative technology solutions, E3 Lithium has the potential to deliver lithium to market from one of the best jurisdictions in the world. 1: The Clearwater Project NI 43-101 Pre-Feasibility Study, effective June 20, 2024, is available on the E3 Lithium's website ( and SEDAR+ ( 2: The mineral resource NI 43-101 Technical Report for the North Rocky Property, effective October 27, 2017, identified 0.9 Mt LCE (inferred) and is available on the E3 Lithium's website ( and SEDAR+ ( 3: The mineral resource NI 43-101 Technical Report for the Estevan Lithium District, effective May 23, 2024, identified 2.5 Mt LCE (inferred) and is available on the E3 Lithium's website ( and SEDAR+ ( Unless otherwise indicated, Kevin Carroll, P. Eng., Chief Development Officer and a Qualified Person under National Instrument 43-101, has reviewed and is responsible for the technical information contained on this news release. Forward-Looking and Cautionary Statements This news release includes certain forward-looking statements as well as management's objectives, strategies, beliefs and intentions. Forward-looking statements are frequently identified by such words as "may", "will", "plan", "expect", "anticipate", "estimate", "intend" and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of mineral exploration and development, fluctuating commodity prices, the effectiveness and feasibility of emerging lithium extraction technologies which have not yet been tested or proven on a commercial scale or on the Company's brine, competitive risks and the availability of financing, as described in more detail in our recent securities filings available at Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. View source version on Contacts E3 Lithium - Investor Relations Alexis de la RenaudiereInvestor Relationsinvestor@ 587-324-2775E3 Lithium - Media Inquiries Kati DolyniukExternal Relationscommunications@ 587-324-2775 Sign in to access your portfolio
